SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹22,622 Cr | ₹18,194 Cr | ₹16,984 Cr | ₹19,906 Cr | ₹17,208 Cr |
What is the latest Total Current Liabilities ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹22,622 Cr |
| Mar2025 | ₹18,194 Cr |
| Mar2024 | ₹16,984 Cr |
| Mar2023 | ₹19,906 Cr |
| Mar2022 | ₹17,208 Cr |
How is Total Current Liabilities of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹22,622 Cr | 24.34 | |
| Mar2025 | ₹18,194 Cr | 7.13 | |
| Mar2024 | ₹16,984 Cr | -14.68 | |
| Mar2023 | ₹19,906 Cr | 15.68 | |
| Mar2022 | ₹17,208 Cr | - | |
Compare Total Current Liabilities of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,229.5 Cr | -1.8% | -3.7% | 17.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹249,673.0 Cr | 3.4% | 10.1% | 57.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,460.0 Cr | 1.6% | 0.8% | 37.8% | Stock Analytics | |
| CIPLA | ₹111,484.0 Cr | -0.4% | -5.6% | -11.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,220.3 Cr | -1.1% | -4.9% | -9.9% | Stock Analytics | |
| MANKIND PHARMA | ₹92,769.9 Cr | -3.6% | -7.4% | -11.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | -1.8% |
-3.7% |
17.2% |
| SENSEX | -1.6% |
-4.2% |
-7.2% |
You may also like the below Video Courses